CopyPastehas never been so tasty!

Tag: “market data

Search Results(1205 results)UserPost DateView
Global Non-small Cell Lung Cancer Dru...

TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 2.77 percent over the period 2012-2016. One of the ke...

anonymous2/12/201354600
Global Over-the-counter Pharmaceuti...

TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 20...

anonymous2/13/20136800
Global Over-the-counter Pharmaceuti...

TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 20...

anonymous2/13/20136600
Global Packaging Survey 2013 - Econo...

Product Synopsis “Global Packaging Industry Survey 2013: Economic Outlook in BRIC” is a new report by Canadean that provides the reader with an exten...

anonymous1/24/20135800
Global Packaging Survey 2013 - Econo...

Product Synopsis “Global Packaging Industry Survey 2013: Economic Outlook in BRIC” is a new report by Canadean that provides the reader with an exten...

anonymous1/24/20134900
Global Packaging Survey 2013 - Econo...

Product Synopsis “Global Packaging Industry Survey 2013: Economic Outlook in BRIC” is a new report by Canadean that provides the reader with an exten...

anonymous1/24/20134600
Global Pharmaceutical & Biotechnolog...

India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited fro...

anonymous1/16/20134700
Global Pharmaceutical & Biotechnolog...

India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited fro...

anonymous1/16/20135700
Global Pharmaceutical & Biotechnolog...

The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi Tanab...

anonymous1/16/20135400
Global Pharmaceutical & Biotechnolog...

The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi Tanab...

anonymous1/16/20134800
...